2012•Journal of Huaihai MedicineRequires access

Regulation of imiquimod on interleukin 18 in the peripheral blood of patient with condyloma acuminatum

Feng Zhang

Open publisher page 0 citations

Abstract

Objective To study the regulation of imiquimod on interleukin 18(IL-18) in the peripheral blood of patient with condyloma acuminatum.Methods 22 adult patients with condyloma acuminatum and 20 healthy controls were sequentially enrolled in this study.Serum levels of IL-18mRNA were measured by real-time polymerase chain reaction in the 22 cases with condyloma acuminatum before and after treatment with imiquimod for 8 weeks and in the 20 healthy controls respectively.Results The serum level of IL-18mRNA before treatment was significantly higher than that of the healthy controls(t=10.82,P0.0001).Expression of serum IL-18mRNA in condyloma acuminatum was significantly decreased after 8 weeks' imiquimod treatment(t=10.74,P0.0001).The serum level of IL-18mRNA was not significantly different between the post-treatment group and the control group(t=1.05,P0.05).Conclusion Our data show that imiquimod could curb the over expression of IL-18mRNA in patients with condyloma acuminatum.

About this research paper

What this paper is about

Objective To study the regulation of imiquimod on interleukin 18(IL-18) in the peripheral blood of patient with condyloma acuminatum.Methods 22 adult patients with condyloma acuminatum and 20 healthy controls were sequentially enrolled in this study.Serum levels of IL-18mRNA were measured by real-time polymerase chain reaction in the 22 cases with condyloma acuminatum before and after treatment with imiquimod for 8 weeks and in the 20 healthy controls respectively.Results The serum level of IL-18mRNA before treatment was significantly higher than that of the healthy controls(t=10.82,P0.0001).Expression of serum IL-18mRNA in condyloma acuminatum was significantly decreased after 8 weeks' imiquimod treatment(t=10.74,P0.0001).The serum level of IL-18mRNA was not significantly different between the post-treatment group and the control group(t=1.05,P0.05).Conclusion Our data show that imiquimod could curb the over expression of IL-18mRNA in patients with condyloma acuminatum.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the regulation of imiquimod on interleukin 18(IL-18) in the peripheral blood of patient with condyloma acuminatum.Methods 22 adult patients with condyloma acuminatum and 20 healthy controls were sequentially enrolled in this study.Serum levels of IL-18mRNA were measured by real-time polymerase chain reaction in the 22 cases with condyloma acuminatum before and after treatment with imiquimod for 8 weeks and in the 20 healthy controls respectively.Results The serum level of IL-18mRNA before treatment was significantly higher than that of the healthy controls(t=10.82,P0.0001).Expression of serum IL-18mRNA in condyloma acuminatum was significantly decreased after 8 weeks' imiquimod treatment(t=10.74,P0.0001).The serum level of IL-18mRNA was not significantly different between the post-treatment group and the control group(t=1.05,P0.05).Conclusion Our data show that imiquimod could curb the over expression of IL-18mRNA in patients with condyloma acuminatum.

Key concepts: Imiquimod, Condyloma Acuminatum, Medicine, Peripheral blood, Interleukin, Immunology, Dermatology, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Regulation of imiquimod on interleukin 18 in the peripheral blood of patient with condyloma acuminatum — Research Paper | ScholarLens